10.6084/m9.figshare.11550561.v1
Alessandro Russo
Alessandro
Russo
Marco Russano
Marco
Russano
Tindara Franchina
Tindara
Franchina
Maria R Migliorino
Maria R
Migliorino
Giuseppe Aprile
Giuseppe
Aprile
Giovanni Mansueto
Giovanni
Mansueto
Alfredo Berruti
Alfredo
Berruti
Alfredo Falcone
Alfredo
Falcone
Michele Aieta
Michele
Aieta
Alain Gelibter
Alain
Gelibter
Antonio Russo
Antonio
Russo
Sandro Barni
Sandro
Barni
Michele Maio
Michele
Maio
Olga Martelli
Olga
Martelli
Francesco Pantano
Francesco
Pantano
Daniela Iacono
Daniela
Iacono
Lorenzo Calvetti
Lorenzo
Calvetti
Silvia Quadrini
Silvia
Quadrini
Elisa Roca
Elisa
Roca
Enrico Vasile
Enrico
Vasile
Marco Imperatori
Marco
Imperatori
Mario Occhipinti
Mario
Occhipinti
Antonio Galvano
Antonio
Galvano
Fausto Petrelli
Fausto
Petrelli
Luana Calabrò
Luana
Calabrò
Giulia Pasquini
Giulia
Pasquini
Salvatore Intagliata
Salvatore
Intagliata
Giuseppina R.R. Ricciardi
Giuseppina R.R.
Ricciardi
Giuseppe Tonini
Giuseppe
Tonini
Daniele Santini
Daniele
Santini
Vincenzo Adamo
Vincenzo
Adamo
Neutrophil-To-Lymphocyte Ratio (NLR) Platelet-To-Lymphocyte Ratio (PLR), and Outcomes With Nivolumab in Pretreated Non-Small Cell Lung Cancer (NSCLC): A Large Retrospective Multicenter Study
Adis Journals
2020
LDH
Nivolumab
NLR
NSCLC
PD-1
PD-L1
PLR
Prognosis
2020-01-27 12:16:53
Figure
https://adisjournals.figshare.com/articles/figure/Neutrophil-To-Lymphocyte_Ratio_NLR_Platelet-To-Lymphocyte_Ratio_PLR_and_Outcomes_With_Nivolumab_in_Pretreated_Non-Small_Cell_Lung_Cancer_NSCLC_A_Large_Retrospective_Multicenter_Study/11550561
<p> </p>
<p><strong>Provide enhanced digital features for this article</strong><br></p><p>
This Figshare page contains a Summary Slide. If you are an author of this publication and
would like to provide additional enhanced digital features for your article
then please contact <u>adisrapidplus@springer.com</u>.<br>
<br>
The journal offers a range of additional features designed to increase
visibility and readership. All features will be thoroughly peer reviewed to
ensure the content is of the highest scientific standard and all features are
marked as ‘peer reviewed’ to ensure readers are aware that the content has been
reviewed to the same level as the articles they are being presented alongside.
Moreover, all sponsorship and disclosure information is included to provide
complete transparency and adherence to good publication practices. This ensures
that however the content is reached the reader has a full understanding of its
origin. No fees are charged for hosting additional open access content.<br>
<br>
Other enhanced features include, but are not limited to:<br>
• Slide decks<br>
• Videos and animations<br>
• Audio abstracts<br>
• Audio slides</p>
<br>
<p> </p>